Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Germany Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20053
20065
20078
20088
20098
20108
20116
20126
20133
20141
20153
20162
20174
20185
20194
20205
20211
20222
20231
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Terminated6
Recruiting3
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S11
Boehringer Ingelheim9
Hoffmann-La Roche9
Eli Lilly and Company7
AstraZeneca6
GlaxoSmithKline5
Sanofi5
MedImmune LLC4
Amgen3
Mannkind Corporation3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 292
Diabetes Mellitus18
Obesity5
Diabetic Nephropathies4
Overweight4
Renal Insufficiency, Chronic4
Albuminuria3
Glucose Intolerance2
Heart Failure2
Hypertension2

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.